ASLN News and Press, ASLAN Pharmaceuticals Limited From 04/12/24

2024-04-12 13:52:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips ASLAN Pharma (NASDAQ: ASLN ) just reported results for the fourth quarter of 2023. ASLAN Pharma reported earnings per share of -78 cents. This was below the analyst estima...

2024-04-12 08:08:56 ET More on ASLAN Pharmaceuticals ASLAN Pharmaceuticals announces $5M registered direct offering Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals Historical earnings data for ASLAN Pharmaceuticals Financial information for ASLAN...

In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a 90% reduction in their EASI score (EASI-90) after 16 weeks. 56% (5/9) of patients with prior inadequate response to dupilumab achieved EASI-90 and 56% (5/9) of patients ...

China Resources Beer (Holdings) Company Limited ADR (CRHKY) is expected to report for Q4 2023 Melco International Development Ltd. (MDEVF) is expected to report for quarter end 2023-12-31 Meridian Mining UK Societas (MRRDF) is expected to report $0 for Q4 2023 BKF Capital Group Inc (B...

SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that management will give a virtual company ...

2024-03-25 17:06:05 ET More on ASLAN Pharmaceuticals ASLAN Pharmaceuticals announces $5M registered direct offering Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals Historical earnings data for ASLAN Pharmaceuticals Financial information for ASLAN...

Bitdeer Technologies Group (BTDR) is expected to report $0.11 for Q4 2023 BioForce Nanosciences Holdings Inc (BFNH) is expected to report for Q4 2023 Casino Guichard Perrachon ADR (CGUSY) is expected to report for quarter end 2023-12-31 Motorsport Games Inc. (MSGM) is expected to repo...

2024-03-17 03:20:00 ET Summary BIO, the global lobbying organization for biotechnology firms, forced WuXi AppTec to leave the group due to pressure from the US Congress. Germany’s Boehringer Ingelheim acquired an option to license drug candidates that treat all symptoms of ...

2024-03-12 16:05:05 ET More on ASLAN Pharmaceuticals Seeking Alpha’s Quant Rating on ASLAN Pharmaceuticals Historical earnings data for ASLAN Pharmaceuticals Financial information for ASLAN Pharmaceuticals Read the full article on Seeking Alpha ...

SAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced today announced that it has entered in...